55 results
8-K
EX-10.2
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
, database right, design right, works for hire and any other intellectual property right, the Licensed Domain Names, and the Know-How (including Commercial
SC 14D9
EX-99
t18ej
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
EX-99
e2dob2b88alkwc
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-T
EX-99
lb570 v0gj49bzjv
6 Jun 22
Third party tender offer statement
5:02pm
8-K
EX-2.1
qwfvj
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
dwj1htu ji
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
S-8
EX-10.1
ngfj0agjb4 rr4z4q2
15 Oct 21
Registration of securities for employees
5:01pm
8-K
cgnif5 z1hm
9 Aug 21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
4:35pm
8-K
EX-10.1
p4qx4
9 Aug 21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
4:35pm
8-K
EX-10.1
bhnjma2 6b
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-10.3
yzc9u69bqb64g5l2
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-10.2
mneu6t8l2gnc2li4f0s
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm